TipRanks
Go Ultimate55% OFF
PC:PSILE

Psilera Inc: Valuation, Funding & Investors

Psilera Inc. is a biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic-derived therapies focused on novel treatments for neuropsychiatric disorders. The company is developing PSIL-006, a first-in-class neuroplastogen designed to provide therapeutic benefits of traditional psychedelic compounds while minimizing hallucinogenic effects and cardiovascular risks, with plans to advance the asset into first-in-human trials.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$9M
Total Funding Rounds
1
Latest Funding Amount
$9M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
May 28, 2026Seed Round$8.80M―

Similar Companies

A snapshot of private companies similar to Psilera Inc, helping you discover and navigate related company profiles.

Related News and Analysis